• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物稳定性研究中动力学建模的数据分析:等温法与非等温法测定

Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.

作者信息

Oliva Alexis, Llabrés Matías, Fariña José B

机构信息

Departamento Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de La Laguna, 38200 La Laguna, Tenerife, Spain.

出版信息

Pharm Res. 2006 Nov;23(11):2595-602. doi: 10.1007/s11095-006-9096-0. Epub 2006 Sep 13.

DOI:10.1007/s11095-006-9096-0
PMID:16969699
Abstract

PURPOSE

Kinetic modelling was applied to predict the stability of cholecystokinin fragment CCK-4 in aqueous solution, which was analyzed by isothermal and nonisothermal methods using a validated stability indicating HPLC method.

METHODS

The isothermal studies were performed in the temperature range 40 to 80 degrees C at pH 12 and ionic strength 0.01 M as constants, whereas nonisothermal stability studies were performed using a linear increasing temperature program, heating rate 0.25 degrees C/h and a temperature interval 40-82 degrees C. The isothermal studies require two-step linear regression to estimate the parameters, resulting in a well-defined confidence interval. Nonisothermal kinetic studies require nonlinear or linear regression by previous transformation of data to estimate the parameters. In this case, the two most popular approaches, derivative and integral, were used and compared.

RESULTS

Under isothermal conditions, an apparent first-order degradation process was observed at all temperatures. The linear Arrhenius plot suggested that the CCK-4 degradation mechanism was the same within the studied temperature range, with quite large uncertainties due to the small number of degrees of freedom based only on the scatter in the plot, and giving an estimated shelf life at 25 degrees C of 35.2 days. The derivative approach yields high variability in the Arrhenius parameters, since they are dependent on the number of polynomial terms chosen, so several statistical criteria were applied to select the best model. The integral approach allows activation parameters to be calculated directly from experimental data, and provides results in good agreement with those of the traditional method, but have the advantage that the uncertainty in the final result directly reflects the goodness of fit of the experimental data to the chosen kinetic model. The application of the bootstrap technique to estimating confidence limits for the Arrhenius parameters and shelf life is also illustrated, and shows there is no difference between the asymptotic and bootstrap confidence intervals.

CONCLUSIONS

Nonisothermal studies give us fast and valuable information about drug stability, although their potential for predicting isothermal behaviour is conditioned by the data analysis method applied.

摘要

目的

应用动力学建模预测胆囊收缩素片段CCK - 4在水溶液中的稳定性,采用经验证的稳定性指示高效液相色谱法通过等温法和非等温法对其进行分析。

方法

等温研究在40至80摄氏度、pH值为12且离子强度为0.01 M的条件下进行,这些条件作为常数;而非等温稳定性研究则采用线性升温程序,升温速率为0.25摄氏度/小时,温度区间为40 - 82摄氏度。等温研究需要两步线性回归来估计参数,从而得到明确的置信区间。非等温动力学研究需要通过对数据进行先前的变换,采用非线性或线性回归来估计参数。在这种情况下,使用并比较了两种最常用的方法,即导数法和积分法。

结果

在等温条件下,在所有温度下均观察到明显的一级降解过程。线性阿伦尼乌斯图表明,在研究的温度范围内,CCK - 4的降解机制相同,但由于仅基于图中的散点的自由度数量较少,存在相当大的不确定性,并给出在25摄氏度下的估计保质期为35.2天。导数法在阿伦尼乌斯参数方面产生高度变异性,因为它们取决于所选多项式项的数量,因此应用了几种统计标准来选择最佳模型。积分法允许直接从实验数据计算活化参数,并提供与传统方法结果良好一致的结果,但具有最终结果的不确定性直接反映实验数据与所选动力学模型拟合优度的优点。还说明了应用自举技术来估计阿伦尼乌斯参数和保质期的置信限,并且表明渐近置信区间和自举置信区间之间没有差异。

结论

非等温研究为我们提供了关于药物稳定性的快速且有价值的信息,尽管它们预测等温行为的潜力受所应用的数据分析方法的制约。

相似文献

1
Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.药物稳定性研究中动力学建模的数据分析:等温法与非等温法测定
Pharm Res. 2006 Nov;23(11):2595-602. doi: 10.1007/s11095-006-9096-0. Epub 2006 Sep 13.
2
Evaluation of non-isothermal methods in stability studies of human insulin pharmaceutical preparations.人胰岛素药物制剂稳定性研究中非等温方法的评估
J Pharm Biomed Anal. 2009 May 1;49(4):916-22. doi: 10.1016/j.jpba.2009.01.024. Epub 2009 Jan 24.
3
Evaluation of cholecystokinin (CCK-8) peptide thermal stability for use as radiopharmaceutical by means isothermal and nonisothermal approaches.采用等温法和非等温法评估用作放射性药物的胆囊收缩素(CCK-8)肽的热稳定性。
Drug Dev Ind Pharm. 2006 Sep;32(8):947-53. doi: 10.1080/03639040600599855.
4
Isothermal and nonisothermal decomposition of thymopentin and its analogs in aqueous solution.胸腺五肽及其类似物在水溶液中的等温与非等温分解
Pharm Res. 1998 Nov;15(11):1702-7. doi: 10.1023/a:1011952511091.
5
Exponential heating in drug stability experiment and statistical evaluation of nonisothermal and isothermal prediction.药物稳定性实验中的指数升温以及非等温与等温预测的统计评估。
J Pharm Sci. 1997 Jun;86(6):709-15. doi: 10.1021/js960398q.
6
Confidence intervals for modeling anthocyanin retention in grape pomace during nonisothermal heating.非等温加热过程中葡萄皮渣中花色苷保留量建模的置信区间
J Food Sci. 2008 Jan;73(1):E9-15. doi: 10.1111/j.1750-3841.2007.00598.x.
7
Nonisothermal stability assessment of stable pharmaceuticals: testing of a clindamycin phosphate formulation.稳定药物的非等温稳定性评估:磷酸克林霉素制剂的测试
Pharm Res. 1991 May;8(5):570-5. doi: 10.1023/a:1015840320410.
8
[Determination of rate order for degradation of drugs with nonisothermal stability experiment].[通过非等温稳定性实验测定药物降解的反应级数]
Yao Xue Xue Bao. 1997;32(2):131-6.
9
Isothermal and nonisothermal decomposition of famotidine in aqueous solution.法莫替丁在水溶液中的等温及非等温分解
Pharm Res. 1995 Apr;12(4):599-604. doi: 10.1023/a:1016222501079.
10
Solid-state stability studies of cholecystokinin (CCK-4) peptide under nonisothermal conditions using thermal analysis, chromatography and mass spectrometry.热分析、色谱和质谱联用研究胆囊收缩素(CCK-4)肽在非等温条件下的固态稳定性。
Eur J Pharm Sci. 2010 Feb 19;39(4):263-71. doi: 10.1016/j.ejps.2009.12.010. Epub 2010 Jan 5.

本文引用的文献

1
Isothermal and nonisothermal decomposition of thymopentin and its analogs in aqueous solution.胸腺五肽及其类似物在水溶液中的等温与非等温分解
Pharm Res. 1998 Nov;15(11):1702-7. doi: 10.1023/a:1011952511091.
2
Determination of rate order for degradation of drugs with nonisothermal stability experiment.
J Pharm Sci. 1997 Oct;86(10):1099-104. doi: 10.1021/js970036y.
3
Exponential heating in drug stability experiment and statistical evaluation of nonisothermal and isothermal prediction.药物稳定性实验中的指数升温以及非等温与等温预测的统计评估。
J Pharm Sci. 1997 Jun;86(6):709-15. doi: 10.1021/js960398q.
4
Estimation of all parameters from nonisothermal kinetic data.
J Pharm Sci. 1982 Sep;71(9):969-74. doi: 10.1002/jps.2600710903.
5
Nonisothermal kinetics applied to drugs in pharmaceutical suspensions.非等温动力学在药物混悬剂中的应用。
Acta Pharm Suec. 1983;20(2):145-54.
6
Nonisothermal kinetics using a microcomputer: a derivative approach to the prediction of the stability of penicillin formulations.使用微型计算机的非等温动力学:一种预测青霉素制剂稳定性的导数方法。
J Pharm Sci. 1983 Jun;72(6):668-73. doi: 10.1002/jps.2600720619.
7
Statistical evaluation of nonisothermal prediction of drug stability.药物稳定性非等温预测的统计评估
J Pharm Sci. 1987 Oct;76(10):794-8. doi: 10.1002/jps.2600761009.
8
Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.肽降解的化学途径。II. 模型六肽中天冬酰胺残基的脱酰胺动力学。
Pharm Res. 1990 Jul;7(7):703-11. doi: 10.1023/a:1015807303766.
9
Stability of gonadorelin and triptorelin in aqueous solution.促性腺激素释放激素和曲普瑞林在水溶液中的稳定性。
Pharm Res. 1990 Dec;7(12):1253-6. doi: 10.1023/a:1015981704133.
10
Characterization of the degradation products of luteinizing hormone releasing hormone.促黄体生成素释放激素降解产物的特性分析
J Pharm Sci. 1991 May;80(5):419-23. doi: 10.1002/jps.2600800504.